Özet:

The epidemic caused by the new type of coronavirus, first under the name SARS-CoV-2 and called COVID-19, has become a global health problem by rapid spread, and the World Health Organization has called the epidemic a pandemic. There is no specific antiviral treatment recommended for the management of COVID-19 disease. The development of alternative therapies aimed at immune response in patients and to reduce the cytocin storm is an important strategy in the improvement of the response to the disease. Strategies aimed at strengthening the home’s immune system in protecting against the disease and in the process of managing the disease are important in fighting the virus and reducing the effects of the disease. Fish oil derived Eikozapentaenoic Acid (EPA) and Docosahekzaenoic Acid (DHA) have biologically strong properties. Omega-3 Multiple Non-Saturated Fatty Acids (PUFA) have a strong immune-modulating activity, and the enrichment of the diet with fish oil causes a decrease in monocyte and neutrophile chemotoxy, reduces the production of pro-inflammatory cytokine and shows anti-inflammatory effects. Studies in critical patients have shown that enteral and parenteral omega-3 PUFA supplements reduce the production of sitocin. Because of these effects on cytokines, omega-3 PUFA is used in acute and chronic inflammatory cases and in the reduction of the immune response that has been improperly activated. The dietary guidelines published on the management of the COVID-19 disease have that the use of fish oil may have potential beneficial effects on the management of the disease. In this collection, the relationship between COVID-19 and omega-3 PUFA was studied and the importance of omega-3 PUFAs for COVID-19 patients was discussed.

Anahtar Kelimeler: